<DOC>
	<DOCNO>NCT02430987</DOCNO>
	<brief_summary>OBJECTIVE : To evaluate prevalence metabolic syndrome postmenopausal woman diagnosis Hypoactive Sexual Desire Disorder . CASUISTIC AND METHODS : This case-control study postmenopausal woman attend Menopause Clinic Faculty Medical Sciences Santa Casa de SÃ£o Paulo . The investigator select woman diagnose HSDD . All woman sign Consentment term . Those select assess prevalence MS ATPIII criterion . Sexual function assess questionnaire Female Sexual Function Index ( FSFI ) . RESULTS : The investigator hope great prevalence MS woman menopause HSDD .</brief_summary>
	<brief_title>Prevalence Metabolic Syndrome Postmenopause Woman With Hypoactive Sexual Desire Disorder</brief_title>
	<detailed_description>The study carry compliance protocol , principle lay Declaration Helsinki ( 1996 Version ) , accordance International Conference Harmonization Harmonized Tripartite Guideline Good Clinical Practice applicable regulatory requirement . The protocol approve Institutional Review Board Independent Ethics Committee . The diagnosis HSDD make clinician experienced train diagnosis female sexual disorder use structured clinical interview FSD Inclusion criterias : - one year amenorrhea - FSH &gt; 30 mUI/mL - participant diagnose generalize acquire HSDD ( i.e. , HSDD limit certain type stimulation , situation , partner develop period normal sexual functioning ) accord American Psychiatric Association 's Diagnostic Statistical Manual Mental Disorders , 4th edition , text revision ( DSM-IV-TR ) criterion &gt; 24 week ' duration . - participant secondary arousal and/or orgasmic disorder arousal orgasmic disorder deem less concern woman HSDD develop HSDD . - Participants monogamous heterosexual relationship &gt; 1 year 's duration sexually functional partner expect physically present &gt; 50 % every month study . - participant willing engage sexual activity ( include sexual intercourse , oral sex , masturbation , genital stimulation partner ) least monthly . - estrogens progestin permit dose stable 6 month prior screen , unless prescribe low sexual desire . Exclusion criterias : - participant form sexual dysfunction , psychiatric disorder could impact sexual function - participant score &gt; 14 Beck Depression Inventory II , suicide ideation accord Columbia Suicide Severity Rating Scale ( C-SSRS ) , history suicidal behavior . - use medication , investigator 's opinion , may affect sexual function follow medication : antiepileptic , CYP3A4 inducer , dopamine agonist parkinsonian drug , metoclopramide , androgens antiandrogens , antiestrogens , fluoxetine long-acting hormonal implant 30 day prior screen , gonadotrophin-releasing hormone analogue hormone inhibitor , benzodiazepine , non-benzodiazepine prescription sleep aid , sedative hypnotic , antidepressant , antipsychotic , mood stabilizer , St. John 's wort , narcotic ( unless use short-term pain relief ) , vaginal lubricants/moisturizers contain warm and/or enhance agent . - participant gynecological disorder endometriosis . - participant significant relationship discord opinion investigator ( conduct extensive diagnostic interview woman part screen process ) .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Hypokinesia</mesh_term>
	<mesh_term>Sexual Dysfunctions , Psychological</mesh_term>
	<criteria>one year amenorrhea FSH &gt; 30 mUI/mL participant diagnose generalize acquire HSDD ( i.e. , HSDD limit certain type stimulation , situation , partner develop period normal sexual functioning ) accord American Psychiatric Association 's Diagnostic Statistical Manual Mental Disorders , 4th edition , text revision ( DSMIVTR ) criteria &gt; 24 week ' duration . Participants monogamous heterosexual relationship &gt; 1 year 's duration sexually functional partner expect physically present &gt; 50 % every month study . Participants willing engage sexual activity ( include sexual intercourse , oral sex , masturbation , genital stimulation partner ) least monthly . Participants significant relationship discord opinion investigator ( conduct extensive diagnostic interview woman part screen process ) exclude study . Participants form sexual dysfunction , psychiatric disorder could impact sexual function . particpant score &gt; 14 Beck Depression Inventory II , suicide ideation accord Columbia Suicide Severity Rating Scale ( CSSRS ) , history suicidal behavior . participant use medication , investigator 's opinion , may affect sexual function follow medication : antiepileptic , CYP3A4 inducer , dopamine agonist parkinsonian drug , metoclopramide , androgens antiandrogens , antiestrogens ( estrogens progestin permit dose stable 6 month prior screen , unless prescribe low sexual desire ) , fluoxetine longacting hormonal implant 30 day prior screen , gonadotrophinreleasing hormone analogue hormone inhibitor , benzodiazepine , nonbenzodiazepine prescription sleep aid , sedative hypnotic , antidepressant , antipsychotic , mood stabilizer , St. John 's wort , narcotic ( unless use shortterm pain relief ) , vaginal lubricants/moisturizers contain warm and/or enhance agent . participant gynecological disorder endometriosis .</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>